Physician profile
John J Lopera
NPI 1417938689
$2,489.18
in general payments reported to CMS, 2019-2025
21 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $332 · 2021: $69.94 · 2022: $134 · 2023: $554 · 2024: $452 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $481.07 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $436.35 | 2019-2025 | |
| Abbott Laboratories | $316.05 | 2019-2024 | Amplatzer Amulet, Gallant |
| Amgen INC. | $236.60 | 2019-2025 | Otezla, Repatha, Repatha |
| Exact Sciences Corporation | $226.86 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $176.81 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $155.85 | 2019-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $69.64 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $60.25 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $53.18 | 2019-2020 | |
| Medtronic, INC. | $42.86 | 2022 | |
| Amarin Pharma, INC. | $37.94 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.84 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.39 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.55 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $23.01 | 2024 | Immunocap |
| Astellas Pharma US INC | $21.83 | 2019 | |
| Hologic Sales and Service, LLC | $21.51 | 2025 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $20.27 | 2024 | |
| Biogen, INC. | $18.52 | 2021 | |
| Allergan, INC. | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lopera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.